    |
 |
 |
| |
|
 平成21年(2009)
1. Xin H, Sun R, Kanehira M, Takahata T, Itoh J, Mizuguchi H, Saijo Y. Intratracheal delivery of
CX3CL1-expressing mesenchymal stem cells to multiple lung tumors. Mol Med. 2009;15:321-7.
2. Inoue A, Kobayashi K, Usui K, Maemondo M, Okinaga S, Mikami I, Ando M, Yamazaki K ,
Saijo Y, Gemma A, Miyazawa H, Tanaka T, Ikebuchi K, Nukiwa T, Morita S, Hagiwara K; North
East Japan Gefitinib Study Group. First-line gefitinib for patients with advanced non-small-cell
lung cancer harboring epidermal growth factor receptor mutations without indication for
chemotherapy.J Clin Oncol. 2009;27:1394-400.
3. 廣瀬勝己、西條康夫：原発不明癌の治療 日本医事新報 第4468号:86-87,2009
4. 佐藤淳也、照井一史、粟津朱美、伊東重豪、西條康夫：外来化学療法における患者満足度の変
遷 癌と化学療法 第36巻11号 1935-1939, 2009.
5. 西條 康夫：固形癌の標準的薬物療法（呼吸器癌・乳癌） 日本内科学会雑誌 ９８巻８号
1860-1865, 2009.
6. 西條 康夫：ことばのカルテCD133 Medical tribune 42巻, 37号、52, 2009
7. 西條 康夫：文献紹介 分子細胞治療 2009;9:316-317
8. 西條 康夫：化学放射線治療向上へ向けてー腫瘍内科医の立場からー 臨床放射線
2009;54:823-828
9. 佐藤輝幸、井上彰、福原達朗、榊原智博、太田洋充、海老名雅仁、西條康夫、貫和敏博：EGFR
遺伝子活性型変異陽性の非小細胞肺癌患者においてゲフィチニブ治療中に認められた耐性形
式の検討：肺癌 2009:49:257-261
|
|
|
平成20年(2008)
1. Inoue A, Sugawara S, Yamazaki K, Maemondo M, Suzuki T, Gomi K, Takanashi S, Inoue C,
Inage M, Yokouchi H, Watanabe H, Tsukamoto T, Saijo Y, Ishimoto O, Hommura F, Nukiwa
Randomized Phase II Trial Comparing Amrubicin With Topotecan in Patients With Previously
Treated Small-Cell Lung Cancer: North Japan Lung Cancer Study Group Trial 0402. J Clin Oncol
26:5401-6, 2008.
2. Inoue A, Xin H, Suzuki T, Kanehira M, Kuroki Y, Fukuhara T, Kikuchi T, Maemondo M, Nukiwa
T, and Saijo Y. Suppression of Surfactant Protein-A by an Epidermal Growth Factor Receptor
Tyrosine Kinase Inhibitor Exacerbates Lung Inflammation. Cancer Science, 99:1679-84, 2008.
3. Narabayashi M, Saijo Y, Takenoshita S, Chida M, Shimoyama N, Miura T, Tani K, Nishimura K,
Onozawa Y, Hosokawa T, Kamoto T, Tsushima T,Opioid Rotation from Oral Morphine to Oral
Oxycodone in Cancer Patients with Intolerable Adverse Effects: An Open-Label Trial Advisory
Committee for Oxycodone Study. Jpn J Clin Oncol 2008.
4. Fukuhara T, Saijo Y, Sakakibara T, Inoue A, Morikawa M, Kanamori M, Nakashima I, and
Nukiwa T. Successful treatment of carcinomatous meningitis using gefitinib and the gefitinib
concentration in cerebrospinal fluid in a patient with lung adenocarcinoma.
Tohoku j.Exp.Med.,2008,214,359-363.
5. Sakakibara T, Saijo Y, Fukuhara T, Gomi K, Inoue K, Ishimoto O, Sugawara S, and Nukiwa T.
Adenocarcinoma with epidermal growth factor receptor gene mutations in three siblings.
J Thorac Oncol, 2008;3:311-3.
6.Kikuchi H, Itoh J, and Fukuda S. Chronic nicotine stimulation modulates the immune response
of mucosal T cells to Th1-dominant pattern via AChR by upregulation of Th1-specific transcriptiona
factor. Neurosci Lett, in press.
7. Yoshiya G, Takahata T, Hanada N, Suzuki K, Ishiguro A, Saito M, Sasaki M, and Fukuda S.
Influence of cancer-related gene polymorphisms on clinicopathological features in colorectal
cancer, J Gastroenterol Hepatol, 23(6),948-953,2008
8. 西條 康夫、肺がん伸展期病態と対症療法 モダンフィジシャン 28: 2008-6, 2008.
9. 西條 康夫、肺癌と癌幹細胞 医学のあゆみ 224: 999-1003, 2008.
|
| |
|
平成19年(2007)
- Zaini J, Andarini S, Tahara M, Saijo Y, Ishii N, Kawakami K, Taniguchi M, Sugamura K, Nukiwa T, and Kikuchi T. OX40 ligand in dendritic cells can costimulate NKT and CD4+ helper T cell antitumor immunity. J. Clin. Invest. 117: 3330-3338, 2007.
2. Kanehira M, Xin H, Hoshino K, Maemondo M, Mizuguchi H, Hayakawa T, Matsumoto K,
Nakamura T, Nukiwa T, and Saijo Y. Targeted delivery of NK4 to the multiple lung tumors by
bone marrow- derived mesenchymal stem cells. Cancer Gene Ther 14: 894-903, 2007.
3. Xin H, Kanehira M, Mizuguchi H, Hayakawa T, Kikuchi T, Nukiwa T, and Saijo Y. Targeted-
delivery of CX3CL1 to multiple lung tumors by mesenchymal stem cells. Stem Cells 25: 1618-
1625, 2007.
4. Kugathasan S, Sauberman L, Smith L, Kou D, Itoh J, Binion D, Levine A, Blumberg R, and Fiocchi C: Mucosal T-cell immunoregulation varies in early and late Crohn’s disease. Gut 56: 1696-1705,
2007.
5. Takeda I, Maruya S, Shirasaki T, Mizukami H, Takahata T, Myers JN, Kakehata S, Yagihashi S,
and Shinawa H. Simvastatin inactivates beta1-integrin and extracellular signal-related kinase
signaling and inhibits cell proliferation in head and neck squamous cell carcinoma cells, Cancer Sci
98: 890- 899,2007
6. Takahata T, Ookawa K, Suto K, Tanaka M, Yano H, Nakashima O, Kojiro M, Tamura Y, Tateishi
T, Sakata Y and Fukuda S, Chemosensitivity Determinants of Irinotecan Hydrochloride in
Hepatocellular Carcinoma Call Lines,Basic clin Pharm Toxicol,102,399-407 2007
7.
西條 康夫、肺癌における化学療法と問題点 アニムス ４７；21-24, 2007.
8. 石黒敦、棟方正樹、設楽紘平、鈴木一広、高畑武功、伊東重豪、青木昌彦、坂田優、棟方昭博、S-
1併用化学放射線療法によりQOLの改善が得られた膵頭部癌の1例、癌と化学療法 34 (6): 937-
940, 2007
9. 石黒敦、棟方正樹、設楽紘平、鈴木一広、高畑武功、伊東重豪、坂田優、棟方昭博、S-1単剤および
肝動注化学療法が奏功している切除不能進行胆のう癌の1例、癌と化学療法 34 (7): 1127-1130,
2007
10. 花畑憲洋、三上達也、福田眞作、西谷大輔、佐々木聡、高畑武功、伊東重豪、佐々木賀広、鬼島
宏 、棟方昭博、早期胃癌を合併したマントル細胞リンパ腫の1例、日本消化器内視鏡学会雑誌
49(7):1674-1680, 2007
11. 佐々木聡、棟方正樹、高畑武功、設楽紘平、武藤理、葛西雅治、坂田優、高濃度酸素療法が有効
であった高齢者腸管嚢腫様気腫症の1例、市立三沢病院医誌 15(1): 33-36, 2007
|
| |
|
| |
|
|
